Satouchi K et al. |
Application of selected ion monitoring to determination of platelet-activating factor. |
1983 |
J. Biochem. |
pmid:6423622
|
McManus LM et al. |
Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit. |
1983 |
Immunopharmacology |
pmid:6832960
|
O'Flaherty JT et al. |
5-L-hydroxy-6,8,11,14-eicosatetraenoate potentiates the human neutrophil degranulating action of platelet-activating factor. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6403011
|
Otsuka A et al. |
alpha-Adrenergic blocking action of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats. |
1983 |
Clin Exp Hypertens A |
pmid:6133661
|
Jouvin-Marche E et al. |
Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils. |
1983 |
Eur. J. Pharmacol. |
pmid:6134631
|
Sano K et al. |
A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. |
1983 |
J. Biol. Chem. |
pmid:6218169
|
Bessin P et al. |
Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. |
1983 |
Eur. J. Pharmacol. |
pmid:6687572
|
Mueller HW et al. |
1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. |
1983 |
Lipids |
pmid:6419001
|
Randolph AE et al. |
Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. |
1983 |
Clin Exp Hypertens A |
pmid:6684006
|
Morley J et al. |
Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. |
1983 |
Br. J. Pharmacol. |
pmid:6685552
|
Hornby EJ and Perry CR |
1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. |
1983 |
Thromb. Haemost. |
pmid:6636035
|
Patterson R and Harris KE |
The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys. |
1983 |
J. Lab. Clin. Med. |
pmid:6644157
|
Nunn B |
Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. |
1983 |
Thromb. Res. |
pmid:6648898
|
Myers A et al. |
Glucocorticoid protection against PAF-acether toxicity in mice. |
1983 |
Br. J. Pharmacol. |
pmid:6652344
|
Virella G et al. |
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes. |
1983 |
Immunology |
pmid:6885111
|
Camussi G et al. |
Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation. |
1983 |
Immunopharmacology |
pmid:6885382
|
O'Flaherty JT and Wykle RL |
Biology and biochemistry of platelet-activating factor. |
1983 |
Clin Rev Allergy |
pmid:6370406
|
Tiffany ML |
Technical considerations for platelet aggregation and related problems. |
1983 |
Crit Rev Clin Lab Sci |
pmid:6370596
|
Camussi G et al. |
The release of platelet-activating factor from human endothelial cells in culture. |
1983 |
J. Immunol. |
pmid:6415166
|
Bonnet J et al. |
Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. |
1983 |
Prostaglandins |
pmid:6419289
|